IN2014DN09779A - - Google Patents
Info
- Publication number
- IN2014DN09779A IN2014DN09779A IN9779DEN2014A IN2014DN09779A IN 2014DN09779 A IN2014DN09779 A IN 2014DN09779A IN 9779DEN2014 A IN9779DEN2014 A IN 9779DEN2014A IN 2014DN09779 A IN2014DN09779 A IN 2014DN09779A
- Authority
- IN
- India
- Prior art keywords
- osteoporosis
- vitamin
- per day
- bone tissue
- drone brood
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 abstract 4
- 229930003231 vitamin Natural products 0.000 abstract 4
- 239000011782 vitamin Substances 0.000 abstract 4
- 229940088594 vitamin Drugs 0.000 abstract 4
- 235000013343 vitamin Nutrition 0.000 abstract 4
- 244000144987 brood Species 0.000 abstract 3
- 208000010392 Bone Fractures Diseases 0.000 abstract 2
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 2
- 229940043430 calcium compound Drugs 0.000 abstract 2
- 150000001674 calcium compounds Chemical class 0.000 abstract 2
- 239000002207 metabolite Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 230000033558 biomineral tissue development Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012115653/15A RU2498811C1 (ru) | 2012-04-19 | 2012-04-19 | Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей |
| PCT/RU2012/000689 WO2013157984A1 (ru) | 2012-04-19 | 2012-08-21 | Препарат и способ профилактики и лечения остеопороза и переломов костей |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09779A true IN2014DN09779A (enrdf_load_stackoverflow) | 2015-07-31 |
Family
ID=49383802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9779DEN2014 IN2014DN09779A (enrdf_load_stackoverflow) | 2012-04-19 | 2014-11-19 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2548776C2 (ru) * | 2013-01-11 | 2015-04-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для ускорения консолидации переломов костей |
| RU2549461C2 (ru) * | 2013-01-11 | 2015-04-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для лечения артритов и артрозов |
| RU2564111C9 (ru) * | 2013-07-03 | 2016-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа |
| RU2593018C1 (ru) * | 2015-10-28 | 2016-07-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ лечения остеоартроза |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743596A (en) * | 1987-06-16 | 1988-05-10 | Lapin Alfred R | Anti-arthritic preparation |
| CN1101684C (zh) * | 1997-07-24 | 2003-02-19 | 薛大权 | 蜂蛹钙制剂 |
| EP1314427A4 (en) * | 2000-08-17 | 2006-05-03 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT FOR THE TREATMENT OF OSTEOPOROSIS |
| CA2526845A1 (en) * | 2003-06-06 | 2005-03-31 | Wyeth | Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby |
| MX2010008906A (es) * | 2008-02-13 | 2010-11-05 | Dsm Ip Assets Bv | Uso combinado de 25-hidroxi-vitamina d3 y vitamina d3 para mejorar la densidad mineral osea y para tratar osteoporosis. |
| FR2945748A1 (fr) * | 2009-05-20 | 2010-11-26 | Debregeas Et Associes Pharma | Medicament a base de calcium et de vitamine d. |
| RU2412616C1 (ru) * | 2009-11-30 | 2011-02-27 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики заболеваний остеопорозом |
| RU2466732C1 (ru) * | 2011-05-31 | 2012-11-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ заполнения полостных образований в метафизарных (трабекулярных) участках костей кальцием и предотвращения выведения из них кальция |
| RU2497533C1 (ru) * | 2012-04-19 | 2013-11-10 | Общество С Ограниченной Ответственностью "Парафарм" | Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме) |
-
2012
- 2012-04-19 RU RU2012115653/15A patent/RU2498811C1/ru active
- 2012-08-21 WO PCT/RU2012/000689 patent/WO2013157984A1/ru active Application Filing
- 2012-08-21 CN CN201280074010.9A patent/CN104379154A/zh active Pending
- 2012-08-21 UA UAA201412409A patent/UA111280C2/uk unknown
- 2012-08-21 EP EP12874726.8A patent/EP2875820A4/en not_active Withdrawn
- 2012-08-21 CA CA2870828A patent/CA2870828C/en active Active
- 2012-08-21 EA EA201401157A patent/EA026534B1/ru unknown
- 2012-08-21 AU AU2012377478A patent/AU2012377478B2/en active Active
- 2012-08-21 US US14/395,482 patent/US20150174176A1/en active Pending
- 2012-08-21 JP JP2015506935A patent/JP6286418B2/ja not_active Expired - Fee Related
- 2012-08-21 BR BR112014025973-9A patent/BR112014025973B1/pt active IP Right Grant
-
2014
- 2014-10-19 IL IL235171A patent/IL235171B/en active IP Right Grant
- 2014-11-19 IN IN9779DEN2014 patent/IN2014DN09779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2875820A4 (en) | 2016-01-27 |
| CN104379154A (zh) | 2015-02-25 |
| EA026534B1 (ru) | 2017-04-28 |
| EA201401157A1 (ru) | 2015-05-29 |
| EP2875820A1 (en) | 2015-05-27 |
| BR112014025973A2 (pt) | 2017-06-27 |
| IL235171B (en) | 2019-09-26 |
| US20150174176A1 (en) | 2015-06-25 |
| IL235171A0 (en) | 2014-12-31 |
| CA2870828C (en) | 2019-01-15 |
| AU2012377478A1 (en) | 2014-12-11 |
| CA2870828A1 (en) | 2013-10-24 |
| JP2015514755A (ja) | 2015-05-21 |
| AU2012377478B2 (en) | 2017-07-06 |
| RU2498811C1 (ru) | 2013-11-20 |
| JP6286418B2 (ja) | 2018-02-28 |
| WO2013157984A1 (ru) | 2013-10-24 |
| AU2012377478A8 (en) | 2014-12-18 |
| UA111280C2 (uk) | 2016-04-11 |
| BR112014025973B1 (pt) | 2021-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| GB201100043D0 (en) | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy | |
| EA201001286A1 (ru) | Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза | |
| IN2014DN09780A (enrdf_load_stackoverflow) | ||
| IN2014DN09779A (enrdf_load_stackoverflow) | ||
| WO2010008976A3 (en) | Combined calcium, magnesium and vitamin d supplements | |
| MX335951B (es) | Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades. | |
| WO2012166003A1 (ru) | Способ заполнения кальцием полостных образований костей | |
| MX2022013681A (es) | Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis. | |
| MX2018005876A (es) | Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas. | |
| MX2012003892A (es) | Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. | |
| JOP20170044B1 (ar) | تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو | |
| MX2020001217A (es) | Metodos de tratamiento de sintomas de gastroparesia usando velusetrag. | |
| RU2008150987A (ru) | Способ лечения переломов длинных трубчатых костей | |
| EA201990553A1 (ru) | Применение придопидина для лечения ухудшения функциональной способности | |
| BR112022003567A2 (pt) | Forma de dosagem oral sólida compreendendo naproxeno e vitamina b1 | |
| Ustun | Gynaecomastia: case report | |
| PL3246032T3 (pl) | Kompozycje farmaceutyczne z kwasem zoledronowym, wapniem i witaminą d, odpowiednie do leczenia i/lub profilaktyki chorób metabolicznych kości oraz działań ubocznych spowodowanych terapią, takich jak hipokalcemia | |
| UA97257U (uk) | Спосіб профілактики та лікування серцево-судинних захворювань | |
| UA53407U (ru) | Способ профилактики и лечения перенашевания беременности | |
| MD667Y (en) | Method for treatment of infectious mononucleosis in children | |
| UA33494U (ru) | Фармацевтическая композиция для лечения заболеваний костной ткани | |
| UA111798C2 (uk) | Спосіб лікування хворих на рак прямої кишки | |
| UA101725U (uk) | Спосіб лікування хворих на рак прямої кишки |